| CASE REPORT |
|
| Year : 2014 | Volume
: 6
| Issue : 1 | Page : 23-24 |
|
|
Trichomegaly of eyelashes after treatment with erlotinib in carcinoma pancreas
Varun Goel1, Shubhra Raina1, D Chandragouda1, Sajjan Singh1, Vineet Talwar1, Nivedita Patnaik2
1 Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India
2 Department of Pathology, University College of Medical Sciences, Guru Teg Bahadur Hospital, New Delhi, India
Correspondence Address:
Varun Goel
Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-7753.136755
|
|
|
Epidermal growth factor receptor (EGFR) inhibitors have been widely used for the treatment of epithelial malignancies. A wide spectrum of skin toxicities have been described in patients receiving EGFR inhibitors. Trichomegaly, especially of the eyelashes is a rare side effect of this therapy. We report a case of trichomegaly of eyelashes in a 39-year-old male, a case of carcinoma pancreas. This side-effect of these medications gives prospects as a therapy to stimulate the growth of hair. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
